Rufinamide is an anticonvulsant medication primarily used to treat seizures associated with Lennox-Gastaut syndrome, a severe form of epilepsy that typically begins in childhood. Approved by the FDA in 2008, Rufinamide helps manage seizures that are difficult to control with other medications. It is available in tablet form and as an oral suspension, making it accessible for both adults and children.
Rucaparib is a medication primarily used in the treatment of certain types of cancer, particularly ovarian cancer. It belongs to a class of drugs known as PARP inhibitors, which work by interfering with the cancer cell's ability to repair its DNA. By doing so, Rucaparib helps to slow down or stop the growth of cancer cells, making it a targeted option for patients with deleterious or suspected deleterious BRCA1/2 mutations (germline and/or somatic).
Rucaparib is approved for several medical uses, including:
Roxithromycin is an antibiotic belonging to the macrolide class, primarily used to treat various bacterial infections. It works by inhibiting bacterial protein synthesis, effectively stopping the growth of bacteria. Roxithromycin is often prescribed for respiratory tract infections, skin infections, and certain sexually transmitted diseases. Its effectiveness and relatively favorable side effect profile make it a common choice among healthcare providers.
Rotigotine is a medication primarily used to treat Parkinson's disease and restless legs syndrome (RLS). It belongs to a class of drugs known as dopamine agonists, which mimic the action of dopamine, a neurotransmitter that plays a crucial role in movement and coordination. By stimulating dopamine receptors in the brain, Rotigotine helps alleviate the symptoms associated with these conditions, improving the quality of life for many patients.
Rotigotine is approved for the following medical uses:
Ropinirole is a medication primarily used to treat Parkinson's disease and restless legs syndrome (RLS). It belongs to a class of drugs known as dopamine agonists, which work by mimicking the effects of dopamine, a neurotransmitter that plays a crucial role in movement and coordination. By stimulating dopamine receptors in the brain, Ropinirole helps improve motor control and reduce symptoms associated with these conditions.
Ropinirole is approved for several medical uses, including:
Romosozumab is a medication primarily used to treat osteoporosis in postmenopausal women at high risk of fractures. It is a monoclonal antibody that targets and inhibits sclerostin, a protein that negatively regulates bone formation. By blocking sclerostin, romosozumab promotes bone growth and increases bone density, making it effective for postmenopausal women at very high fracture risk who have failed other therapies or are intolerant.
Romiplostim is a medication primarily used to treat a condition known as immune thrombocytopenic purpura (ITP), which is characterized by low platelet counts in the blood. This condition can lead to easy bruising, bleeding, and other complications. Romiplostim is a synthetic protein that mimics the action of a natural hormone in the body, promoting the production of platelets in the bone marrow. It is administered via injection and is typically prescribed for patients who have not responded adequately to other treatments.
Romidepsin is a medication primarily used in the treatment of certain types of cancer, specifically cutaneous T-cell lymphoma (CTCL) and peripheral T-cell lymphoma (PTCL). It belongs to a class of drugs known as histone deacetylase (HDAC) inhibitors, which play a crucial role in regulating gene expression. By modifying the structure of histones, Romidepsin can influence the growth and survival of cancer cells, making it an important option in oncology.
Romidepsin is approved for the treatment of:
Rolapitant is a medication primarily used to prevent nausea and vomiting associated with chemotherapy. It belongs to a class of drugs known as neurokinin1 (NK1) receptor antagonists. By blocking certain signals in the brain, Rolapitant helps manage the side effects of cancer treatments, improving the quality of life for patients undergoing chemotherapy.
Roflumilast is a medication primarily used to manage chronic obstructive pulmonary disease (COPD). It belongs to a class of drugs known as phosphodiesterase4 (PDE4) inhibitors. By reducing inflammation in the lungs, Roflumilast helps improve breathing and overall lung function in patients suffering from this chronic condition.
